logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

AACR 2018 — 124I-8H9-directed radioimmuno-PET shows promise in DSRCT

Phase 1 study of radioiodinated 8H9 to evaluate toxicity, pharmacokinetics, biodistribution and efficacy